Page last updated: 2024-10-25

clonidine and ADDH

clonidine has been researched along with ADDH in 190 studies

Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.

Research Excerpts

ExcerptRelevanceReference
"A pilot comparison of the safety and efficacy of methylphenidate (MPH) combined with clonidine, clonidine monotherapy, or MPH monotherapy in 6- to 16-year-old children diagnosed with attention deficit hyperactivity disorder (ADHD) and comorbid aggressive oppositional defiant disorder or conduct disorder was completed."9.09A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. ( Barkley, RA; Connor, DF; Davis, HT, 2000)
"8 years) with autistic disorder, diagnosed by DSM-III-R criteria, completed a placebo-controlled, double-blind crossover trial of clonidine."9.07Clonidine treatment of hyperactive and impulsive children with autistic disorder. ( Cook, EH; Fletcher, KE; Jaselskis, CA; Leventhal, BL, 1992)
"Atomoxetine and OROS methylphenidate were successfully used concomitantly in a 10-year-old boy suffering from attention-deficit/hyperactivity disorder (ADHD) with comorbid bipolar disorder and Tourette syndrome (TS)."7.73Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome. ( Benarroch, F; Gross-Tsur, V; Jaworowski, S, 2006)
"We concluded that the incidence of clonidine poisoning had increased over the specified period and that, based on our results, this was likely to be due to an increase in clonidine use in childhood behavioural disorders."7.70Clonidine poisoning--an emerging problem: epidemiology, clinical features, management and preventative strategies. ( Duncan, A; Erickson, SJ, 1998)
"Clonidine is an alpha-adrenergic agonist which may alleviate emerging symptoms in Tourette syndrome, an observation that has fueled speculation regarding involvement of stress-sensitive central noradrenergic systems in this disorder."7.69Predictors of clonidine response in Tourette syndrome: implications and inferences. ( Jackson, LA; Lichter, DG, 1996)
"Treatment of sleep disorders can be difficult in these children."6.73Use of clonidine in children with autism spectrum disorders. ( Gordon, E; Kang, N; Ming, X; Wagner, GC, 2008)
"There were more incidents of bradycardia in subjects treated with clonidine compared with those not treated with clonidine (17."5.13Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis. ( Bukstein, OG; Daviss, WB; Harris, P; McDERMOTT, MP; Palumbo, D; Patel, NC; Pelham, WE; Robb, AS; Sallee, FR, 2008)
"A pilot comparison of the safety and efficacy of methylphenidate (MPH) combined with clonidine, clonidine monotherapy, or MPH monotherapy in 6- to 16-year-old children diagnosed with attention deficit hyperactivity disorder (ADHD) and comorbid aggressive oppositional defiant disorder or conduct disorder was completed."5.09A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. ( Barkley, RA; Connor, DF; Davis, HT, 2000)
"8 years) with autistic disorder, diagnosed by DSM-III-R criteria, completed a placebo-controlled, double-blind crossover trial of clonidine."5.07Clonidine treatment of hyperactive and impulsive children with autistic disorder. ( Cook, EH; Fletcher, KE; Jaselskis, CA; Leventhal, BL, 1992)
" The study aimed to determine the risk of TBI in TS patients, the effects associated with concurrent psychiatric disorders (attention-deficit/hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD), or depressive disorder), and the effects of medication treatment (antipsychotics, antidepressants, or clonidine) on the risk of TBI."3.91Tourette's syndrome is associated with an increased risk of traumatic brain injury: A nationwide population-based cohort study. ( Chen, SF; Hsu, CY; Shen, YC; Su, YC; Wang, LY, 2019)
" The authors identified children with ≥1 clonidine prescription; the authors examined their ICD-9 diagnoses categorized as simple and complex attention deficit hyperactivity disorder (ADHD), non-ADHD mental health disorder, hypertension, or others."3.78Clonidine utilization trends for Medicaid children. ( Clark, SJ; Cohn, L; Kershaw, D; Rocchini, A; Yoon, EY, 2012)
"This paper reports on the use of clonidine for the treatment of severe sleep problems associated with behavioural difficulties in children with neurodevelopmental disabilities."3.73The use of clonidine for severe and intractable sleep problems in children with neurodevelopmental disorders--a case series. ( Ingrassia, A; Turk, J, 2005)
"Atomoxetine and OROS methylphenidate were successfully used concomitantly in a 10-year-old boy suffering from attention-deficit/hyperactivity disorder (ADHD) with comorbid bipolar disorder and Tourette syndrome (TS)."3.73Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome. ( Benarroch, F; Gross-Tsur, V; Jaworowski, S, 2006)
"We concluded that the incidence of clonidine poisoning had increased over the specified period and that, based on our results, this was likely to be due to an increase in clonidine use in childhood behavioural disorders."3.70Clonidine poisoning--an emerging problem: epidemiology, clinical features, management and preventative strategies. ( Duncan, A; Erickson, SJ, 1998)
"Clonidine is an alpha-adrenergic agonist which may alleviate emerging symptoms in Tourette syndrome, an observation that has fueled speculation regarding involvement of stress-sensitive central noradrenergic systems in this disorder."3.69Predictors of clonidine response in Tourette syndrome: implications and inferences. ( Jackson, LA; Lichter, DG, 1996)
"Growth hormone (GH) and beta-endorphin (beta-EP) responses to clonidine stimulation were examined in 18 male heroin addicts, 9 with and 9 without previous histories of attention deficit disorder with hyperactivity (ADD-H) and conduct disorder (CD)."3.69Alpha-2-adrenoceptor sensitivity in heroin addicts with and without previous attention deficit disorder/hyperactivity and conduct disorder. ( Avanzini, P; Brambilla, F; Caccavari, R; Delsignore, R; Fertonani-Affini, G; Fontanesi, B; Gerra, G; Maestri, D; Marcato, A; Perna, G, 1994)
"Growth hormone (GH) and 3-methoxy-4-hydroxyphenelethylene glycol (MHPG) response was measured hourly for 4 hours in 8 children with Attention Deficit Disorder with Hyperactivity (ADD+H) following an acute single-dose of clonidine."3.67Possible change in noradrenergic receptor sensitivity following methylphenidate treatment: growth hormone and MHPG response to clonidine challenge in children with attention deficit disorder and hyperactivity. ( Anderson, G; Clark, L; Cohen, DJ; Hunt, RD, 1984)
"Clonidine was effective in improving the hyperactivity and impulsivity symptoms in children with ADHD as compared to carbamazepine."2.74Randomised controlled study-efficacy of clonidine versus carbamazepine in children with ADHD. ( Mahadevan, S; Nair, V, 2009)
"Clonidine was well tolerated despite the frequency of sedation and did offer some benefit."2.73Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes. ( Bukstein, OG; Daviss, WB; McDERMOTT, MP; Palumbo, DR; Pelham, WE; Sallee, FR, 2008)
"Treatment of sleep disorders can be difficult in these children."2.73Use of clonidine in children with autism spectrum disorders. ( Gordon, E; Kang, N; Ming, X; Wagner, GC, 2008)
"Lofexidine was associated with insignificant decreases in blood pressure and pulse."2.71A placebo-controlled study of lofexidine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. ( Mair, A; Niederhofer, H; Staffen, W, 2003)
"All had comorbid mental retardation."2.70Double-blind, placebo-controlled trial of clonidine in hyperactive children with mental retardation. ( Agarwal, V; Kumar, S; Prasad, M; Sitholey, P, 2001)
" Transient sedation lasting 2 to 3 days occurred after initial administration or dosage increase; otherwise, clonidine was well tolerated."2.67Clonidine therapy for comorbid attention deficit hyperactivity disorder and conduct disorder: preliminary findings in a children's inpatient unit. ( Mandoki, MW; Schvehla, TJ; Sumner, GS, 1994)
" In one study, tics limited further dosage increases of methylphenidate."2.58Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders. ( Osland, ST; Pringsheim, T; Steeves, TD, 2018)
" Clonidine, melatonin, L-theanine, eszopiclone and guanfacine were well tolerated with mild to moderate adverse events; zolpidem was associated with neuropsychiatric adverse effects."2.55Safety, Tolerability and Efficacy of Drugs for Treating Behavioural Insomnia in Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review with Methodological Quality Assessment. ( Anand, S; Besag, FMC; Chan, EW; Cortese, S; Tong, H; Wong, ICK, 2017)
" Withdrawals due to all-cause, adverse effects and lack of efficacy were defined as primary outcomes evaluating the safety of such medications."2.55An Evaluation on the Efficacy and Safety of Treatments for Attention Deficit Hyperactivity Disorder in Children and Adolescents: a Comparison of Multiple Treatments. ( Gao, J; He, S; Li, Y; Wang, Q; Zhang, Y, 2017)
"Desipramine and placebo were similar on "all-cause treatment discontinuation" (RD -0."2.50Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents. ( Castells, X; Ehimare, UP; Otasowie, J; Smith, CH, 2014)
" While medications for ADHD are generally well-tolerated, there are common, although less severe, as well as rare but severe adverse events AEs during treatment with ADHD drugs."2.49Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. ( Banaschewski, T; Buitelaar, J; Coghill, D; Cortese, S; Danckaerts, M; Dittmann, RW; Graham, J; Holtmann, M; Sergeant, J; Taylor, E, 2013)
"Clonidine reduced insomnia; and melatonin also exhibited a positive response, with reduced sleep latency, higher total sleep time, and higher sleep efficiency."2.49To sleep or not to sleep: a systematic review of the literature of pharmacological treatments of insomnia in children and adolescents with attention-deficit/hyperactivity disorder. ( Barrett, JR; Giaroli, G; Tracy, DK, 2013)
"Clonidine XR was generally well tolerated as monotherapy and as adjunctive therapy with stimulant regimens in clinical trials in children and adolescents."2.47Clonidine extended-release: in attention-deficit hyperactivity disorder. ( Croxtall, JD, 2011)
" This review focuses on the tolerability, occurrence of adverse events, precautions required to prevent severe adverse events, and essential pharmacological interaction in the treatment of ADHD symptoms by non-stimulants."2.43The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder. ( Banaschewski, T; Heise, CA; Himpel, S; Rothenberger, A, 2005)
"Clonidine is a good option for managing core behavioral symptoms, especially hyperactivity and impulsivity."2.43Advances in alternative pharmacotherapy of ADHD. ( Pityaratstian, N, 2005)
" Methylphenidate and amphetamine-based stimulants are now available in longer-acting, once-daily and shorter-acting divided dosing schedules."2.42Pharmacological management of attention-deficit hyperactivity disorder. ( Reeves, G; Schweitzer, J, 2004)
" A recent group of placebo-controlled, double-blinded clinical trials have consistently shown that certain stimulants, particularly methylphenidate and dextroamphetamine, are effective, well tolerated, and safe when administered to treat ADHD in children with tics."2.42Tourette's syndrome: are stimulants safe? ( Kurlan, R, 2003)
"Tourette's disorder is a neuropsychiatric disorder characterised clinically by motor and vocal tics, which may be associated to conductual disorders such as obsessive-compulsive disorder (OCD) and attention-deficit hyperactivity disorder (ADHD)."2.41Pharmacological options for the treatment of Tourette's disorder. ( García-Ruiz, PJ; Jiménez-Jiménez, FJ, 2001)
"Clonidine has not been adequately examined but seems to have small or uncertain effects."2.40Antidepressants in the treatment of attention-deficit/hyperactivity disorder. ( Popper, CW, 1997)
"Patients with Korsakoff's disease, attention deficit disorder or schizophrenia may benefit from treatment with alpha 2-agents."2.39Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition. ( Coull, JT, 1994)
" Included are the drugs' putative mechanisms of action, pharmacology, toxicology, indications for their use, short-term and long-term actions, adverse effects, specific dosing regimens, therapeutic monitoring techniques, alternative medications, and drug interactions."2.38Pharmacologic treatment of attention deficit hyperactivity disorder. ( Greenhill, LL, 1992)
"Clonidine effectively alleviates tic symptoms, reduces attention deficit and hyperactivity/impulsivity in children with tic disorder co-morbid attention deficit hyperactivity disorder, and features a high safety profile."1.91Efficacy of clonidine in the treatment of children with tic disorder co-morbid with attention deficit hyperactivity disorder. ( Hu, B; Huang, XH; Wang, GL; Yuan, Y; Zeng, KD; Zhang, W, 2023)
"Clonidine was the most common medication to be used and was well tolerated."1.48Implications of comorbid ADHD in ASD interventions and outcome: Results from a naturalistic follow up study from south India. ( Chandrasekaran, V; Kandasamy, P; Kuppili, PP; Manohar, H; Rajkumar, RP, 2018)
" The IR forms, while themselves not FDA approved for ADHD, may, with dosage adjustment, be reasonable alternatives (with considerable cost savings)."1.43Treating ADHD in Prison: Focus on Alpha-2 Agonists (Clonidine and Guanfacine). ( Mattes, JA, 2016)
" Dexmethylphenidate XR is a stimulant treatment in a single isomer form, and has an efficacy and tolerability similar to two doses of immediate-release (IR) dexmethylphenidate when taken 4 hours apart, but is dosed at half of the usual d,l-methylphenidate dose."1.36Attention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy. ( Kratochvil, CJ; May, DE, 2010)
"Clonidine users were characterized on the basis of demographics, comorbid conditions, medication use and provider types, and prescribing patterns before and after the index atomoxetine prescription assessed."1.33Decreased use of clonidine following treatment with atomoxetine in children with ADHD. ( Johnston, JA; Pohl, G; Sumner, CR; Van Brunt, DL; Ye, W, 2006)
" The in vitro release rate of the clonidine from KBD-TTS significantly correlated with the in vivo absorption rate (p<0."1.33In vitro and in vivo characterization of a newly developed clonidine transdermal patch for treatment of attention deficit hyperactivity disorder in children. ( Guo, HY; Ke, GM; Lu, WL; Wang, L; Xue, HY; Zhang, Q; Zhang, X, 2005)
"Pharmacological treatment of epilepsy is needed whenever epilepsy occurs."1.31[Medical treatment of fragile X syndrome]. ( Artigas-Pallarés, J; Brun-Gasca, C, 2001)
"Criteria of attention deficit disorder with hyperactivity are defined in DSM IV and CIM 10."1.31[Attention deficit disorder with hyperactivity in children: diagnosis and therapeutic management]. ( Vallée, L, 2000)
"Treatment with methylphenidate was more effective and better tolerated than treatment with clonidine."1.31[Functioning, comorbidity and treatment of 141 adults with attention deficit hyperactivity disorder (ADHD) at a psychiatric outpatient department]. ( Aeckerlin, LP; Buitelaar, JK; Kooij, JJ, 2001)
"While most of the clonidine exposures resulted in minimal toxic effects, serious toxic effects and death can occur."1.31Trends and toxic effects from pediatric clonidine exposures. ( Klein-Schwartz, W, 2002)
"Clonidine overdose is a potentially serious condition, often requiring intensive care management."1.30Clonidine overdose in childhood: implications of increased prescribing. ( Hanson, RM; Hutchins, P; Kappagoda, C; Schell, DN, 1998)
"Clonidine was helpful in ameliorating these behaviors."1.29Case study: behavioral symptoms of pediatric HIV-1 encephalopathy successfully treated with clonidine. ( Cebollero, AM; Ceseña, M; Lee, DO; Steingard, RJ, 1995)
"Because in many patients with Tourette's syndrome (TS) the ADHD symptoms are the major source of disability, alternative nonstimulant treatments are needed."1.29Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome. ( Biederman, J; Spencer, T; Steingard, R; Wilens, T, 1993)
"Clonidine treatment resulted in improvement in both the ADHD (39/54; 72%) and tic symptoms (18/24; 75%) groups."1.29Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders. ( Biederman, J; Gonzalez, A; Spencer, T; Steingard, R; Wilens, T, 1993)
" This article is a guide to its usage in children and includes discussion of its indications, contraindications, pre-treatment laboratory studies, dosing and drug interactions."1.29Clonidine: a practical guide for usage in children. ( Oesterheld, J; Tervo, R, 1996)
"Tourette syndrome is a neuropsychiatric disorder of motor and vocal tics, with associated symptoms of obsessive-compulsive behaviors and attention deficit disorder with hyperactivity."1.27[The treatment of children with Gilles de la Tourette's syndrome]. ( Minderaa, RB, 1987)

Research

Studies (190)

TimeframeStudies, this research(%)All Research%
pre-199014 (7.37)18.7374
1990's58 (30.53)18.2507
2000's58 (30.53)29.6817
2010's52 (27.37)24.3611
2020's8 (4.21)2.80

Authors

AuthorsStudies
Newcorn, JH4
Krone, B1
Dittmann, RW2
Pipe, A1
Ravindran, N1
Paric, A1
Patterson, B1
Van Ameringen, M1
Ravindran, AV1
Zammit, J3
Ferrafiat, V3
Bang Madsen, K1
Robakis, TK1
Liu, X1
Momen, N1
Larsson, H1
Dreier, JW1
Kildegaard, H1
Groth, JB1
Hove Thomsen, P1
Munk-Olsen, T1
Bergink, V1
Zeng, KD1
Wang, GL1
Yuan, Y1
Zhang, W1
Huang, XH1
Hu, B1
Miller, J1
Perera, B1
Shankar, R1
Cutler, AJ1
Mattingly, GW2
Jain, R4
O'Neal, W1
Cortese, S6
Coghill, D4
Anand, S1
Tong, H1
Besag, FMC1
Chan, EW1
Wong, ICK1
Naguy, A3
Danborg, PB1
Simonsen, AL1
Gøtzsche, PC1
Manohar, H1
Kuppili, PP1
Kandasamy, P1
Chandrasekaran, V1
Rajkumar, RP1
Osland, ST1
Steeves, TD1
Pringsheim, T2
Adamo, N2
Del Giovane, C2
Mohr-Jensen, C2
Hayes, AJ2
Carucci, S2
Atkinson, LZ2
Tessari, L1
Banaschewski, T4
Hollis, C1
Simonoff, E2
Zuddas, A2
Barbui, C2
Purgato, M2
Steinhausen, HC2
Shokraneh, F2
Xia, J2
Cipriani, A2
Elsori, D1
Alamiri, B1
Chen, SF1
Su, YC1
Wang, LY1
Hsu, CY1
Shen, YC1
Sallee, F1
Connor, DF5
Beckmann, KM1
Fernández-Jaén, A1
Martín Fernández-Mayoralas, D1
Fernández-Perrone, AL1
Calleja-Pérez, B1
Muñoz-Jareño, N1
López-Arribas, S1
Nguyen, M1
Tharani, S1
Rahmani, M1
Shapiro, M1
Barrett, JR1
Tracy, DK1
Giaroli, G1
Efron, D1
Lycett, K1
Sciberras, E1
Kawaura, K1
Karasawa, J1
Chaki, S1
Hikichi, H1
Otasowie, J1
Castells, X1
Ehimare, UP1
Smith, CH1
Wrenn, CC1
Heitzer, AM1
Roth, AK1
Nawrocki, L1
Valdovinos, MG1
Sohn, M1
Talbert, J1
Moga, DC1
Blumenschein, K1
Chan, E1
Fogler, JM1
Hammerness, PG1
Mattes, JA1
Li, Y1
Gao, J1
He, S1
Zhang, Y1
Wang, Q1
Katic, A1
Anderson, RH1
Bhatti, S1
Ghanizadeh, A1
Nair, V1
Mahadevan, S1
Scahill, L3
Cannon, M1
Pelham, WH1
Sallee, FR5
Palumbo, DR2
Bukstein, O1
Daviss, WB3
May, DE1
Kratochvil, CJ3
Glazer, WM1
Rowles, BM1
Findling, RL3
Segal, S2
Kollins, SH3
Khayrallah, M2
Vorobyov, V1
Schibaev, N1
Kaptsov, V1
Kovalev, G1
Sengpiel, F1
Dowben, JS1
Grant, JS1
Keltner, NL1
Brams, M1
Wigal, SB2
Bidwell, LC1
McClernon, FJ1
Huang, YS1
Tsai, MH1
Keen, D1
Hadijikoumi, I1
Leggett, C1
Hotham, E1
Croxtall, JD2
Roman, MW1
Clement, HW1
Schulz, E1
Rickards, H1
Cavanna, AE1
Worrall, R1
De Benedictis, L1
Dumais, A1
Landry, P1
Saddichha, S1
Vibha, P1
Vishnuvardhan, G1
Duong, S1
Chung, K1
Childress, AC1
Yoon, EY1
Cohn, L1
Rocchini, A1
Kershaw, D1
Clark, SJ1
Lachaine, J1
Beauchemin, C1
Sasane, R1
Hodgkins, PS1
Holtmann, M1
Buitelaar, J1
Danckaerts, M1
Graham, J1
Taylor, E2
Sergeant, J2
Kornfield, R1
Watson, S1
Higashi, AS1
Conti, RM1
Dusetzina, SB1
Garfield, CF1
Dorsey, ER1
Huskamp, HA1
Alexander, GC1
Suchard, JR1
Graeme, KA1
Ramchandani, P3
Joughin, C3
Zwi, M3
Artigas-Pallarés, J1
Brun-Gasca, C1
Levenson, D1
Mao, ZM1
Li, BM1
Arnsten, AF4
Niederhofer, H2
Staffen, W1
Mair, A1
Kurlan, R1
Kano, Y1
Biederman, J7
Spencer, T5
Wilens, T5
Reeves, G1
Schweitzer, J1
Symons, FJ1
Thompson, A1
Realmuto, G1
McDougle, CJ1
Ke, GM1
Wang, L1
Xue, HY1
Lu, WL1
Zhang, X1
Zhang, Q1
Guo, HY1
Johnson, LA1
Safranek, S1
Friemoth, J1
Ingrassia, A1
Turk, J1
Himpel, S1
Heise, CA1
Rothenberger, A1
Lake, M1
Pliszka, SR1
Walkup, JT2
Shah, M1
Cork, C1
Chowdhury, U1
Wolraich, ML1
Wibbelsman, CJ1
Brown, TE1
Evans, SW1
Gotlieb, EM1
Knight, JR1
Ross, EC1
Shubiner, HH1
Wender, EH1
Pritchard, D2
Ambalavanan, G1
Holten, KB1
McDonald, CA1
Guttinger, R1
Joyce, D1
Mendhekar, DN1
Faraone, SV1
Doyle, AE1
Spencer, TJ3
Wilens, TE5
Weiss, MD1
Safren, SA1
Culpepper, L1
Rains, A1
Hamrin, V1
Lecendreux, M1
Mouren, MC1
Konofal, E1
Pityaratstian, N1
Varley, C1
Cummins, TK1
Martin, A1
Jaworowski, S1
Benarroch, F1
Gross-Tsur, V1
Johnston, JA1
Ye, W1
Van Brunt, DL1
Pohl, G1
Sumner, CR1
Prasad, S1
Harpin, V1
Poole, L1
Zeitlin, H1
Jamdar, S1
Puvanendran, K1
Kotcher, L1
Wieland, N1
Coffey, B1
Stella, MJ1
Bailey, AG1
Patel, NC2
Robb, AS1
McDERMOTT, MP2
Bukstein, OG2
Pelham, WE2
Palumbo, D1
Harris, P1
Feron, FJ1
Hendriksen, JG1
Nicolai, J1
Vles, JS1
Ming, X1
Gordon, E1
Kang, N1
Wagner, GC1
Sears, J1
Hunt, RD8
Cohen, DJ10
Shaywitz, SE2
Shaywitz, BA3
Leckman, JF4
Anderson, G1
Clark, L1
Bruun, RD1
Gertner, JM1
Ort, S2
Harcherik, DF1
Wolf, A1
Loomis, R1
Kwasman, A1
Tinsley, BJ1
Lepper, HS1
Singer, HS2
Brown, J1
Quaskey, S1
Rosenberg, LA1
Mellits, ED1
Denckla, MB1
Wozniak, J1
Connor, D1
Scahill, LD1
Riddle, MA2
Ceseña, M1
Lee, DO1
Cebollero, AM1
Steingard, RJ1
Gerra, G1
Caccavari, R1
Fontanesi, B1
Delsignore, R1
Fertonani-Affini, G1
Marcato, A1
Maestri, D1
Avanzini, P1
Perna, G1
Brambilla, F1
Coull, JT1
Horacek, HJ1
Schvehla, TJ1
Mandoki, MW1
Sumner, GS1
Culbert, TP1
Banez, GA1
Reiff, MI1
Fargason, RE1
Ford, CV1
Chapman, NA1
Rubinstein, S1
Silver, LB1
Licamele, WL1
Gunning, WB2
Hoehn, R1
Stephens, KJ1
Riley, W1
Osten, C1
Steingard, R3
Geist, D1
Gonzalez, A1
Steere, JC1
St Dennis, C1
Synoground, G1
Ryan, MG1
Oesterheld, J1
Tervo, R1
Pearson, CC1
Lichter, DG1
Jackson, LA1
Weaver, A1
Eppright, TD1
Stern, BL1
Reid, J1
Horwitz, E1
Kooij, JJ2
Goekoop, JG1
Prince, JB1
Wozniak, JR1
Cantwell, DP1
Swanson, J1
Hagerman, R1
Popper, CW1
Peterson, BS1
Erickson, SJ1
Duncan, A1
Ryan, ND1
Doepfner, M1
Gunning, B2
Overmeyer, S1
Möbius, HJ1
Eisert, HG1
Broderick-Cantwell, JJ1
Levy, F1
Kappagoda, C1
Schell, DN1
Hanson, RM1
Hutchins, P1
van der Meere, J1
Stemerdink, N1
Swanson, JM2
Cantwell, D1
Weller, EB1
Rowan, A1
Elia, J1
Weller, RA1
King, VL1
Brooner, RK1
Kidorf, MS1
Stoller, KB1
Mirsky, AF1
Kofoed, L1
Tadepalli, G1
Oesterheld, JR1
Awadallah, S1
Shapiro, R1
Dech, B1
Fletcher, KE2
Barkley, RA1
Davis, HT1
Kalb, C1
Vallée, L1
Agarwal, V1
Sitholey, P1
Kumar, S1
Prasad, M1
Romano, MJ1
Dinh, A1
Aeckerlin, LP1
Buitelaar, JK2
Gianarris, WJ1
Golden, CJ1
Greene, L1
Jiménez-Jiménez, FJ1
García-Ruiz, PJ1
Klein-Schwartz, W1
Sawyer, MG1
Rey, JM1
Graetz, BW1
Clark, JJ1
Baghurst, PA1
Greenhill, LL1
Jaselskis, CA1
Cook, EH1
Leventhal, BL1
Vink, HJ1
Althaus, M1
Goorhuis-Brouwer, SM1
Minderaa, RB4
Hart-Santora, D1
Hart, LL1
van der Gaag, RJ1
Polák, L1
Molcan, J1
Comings, DE1
Comings, BG1
Tacket, T1
Li, SZ1
Caruso, KA1
Anderson, GM1
Kremenitzer, M1
Caine, ED1
McBride, MC1
Chiverton, P1
Bamford, KA1
Rediess, S1
Shiao, J1
Jensen, JB1
Garfinkel, BD1
Huisjes, HJ1
Hadders-Algra, M1
Touwen, BC1

Clinical Trials (9)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
An Observational Study Investigating the Experience of Patients Undergoing Active Insomnia Clinical Trials[NCT05978271]500 participants (Anticipated)Observational2024-08-31Not yet recruiting
The Effects of Methylphenidate (MPH) and Non-invasive Brain Stimulation (tDCS) on Inhibitory Control Children With Attention-Deficit/Hyperactivity Disorder (ADHD)[NCT04964427]26 participants (Actual)Interventional2021-02-08Completed
Open Label Study for the Use of Transcranial Ultrasound Treatment of Attention Deficit Hyperactive Disorder[NCT04497363]100 participants (Anticipated)Interventional2020-07-01Enrolling by invitation
Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) Treatment (CAT)[NCT00031395]Phase 3122 participants (Actual)Interventional1999-09-30Completed
A Phase III, Dose-Response Evaluation of the Efficacy and Safety of CLONICEL® (Clonidine HCl Sustained Release) vs. Placebo in the Treatment of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)[NCT00556959]Phase 3236 participants (Actual)Interventional2007-10-31Completed
Efficacy of Pharmacologic Management of ADHD in Children and Youth With Autism Spectrum Disorder[NCT05916339]Phase 4500 participants (Anticipated)Interventional2023-10-01Not yet recruiting
Therapeutic Use of Repetitive Transcranial Magnetic Stimulation (rTMS) in Pediatric Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Cohorts (ADHD): a Randomized, Sham-controlled Study.[NCT06069323]80 participants (Anticipated)Interventional2023-06-01Recruiting
[NCT00004325]200 participants Observational1988-12-31Completed
A Single-blind, Randomised, Sham Controlled, Phase IIa Exploratory Clinical Trial, to Examine the Safety and Efficacy of BGX-3006 (tPCS) on Paediatric ADHD Participants.[NCT02323633]Phase 248 participants (Anticipated)Interventional2015-01-31Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

71 reviews available for clonidine and ADDH

ArticleYear
Nonstimulant Treatments for ADHD.
    Child and adolescent psychiatric clinics of North America, 2022, Volume: 31, Issue:3

    Topics: Adrenergic alpha-2 Receptor Agonists; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyp

2022
Treatments for child and adolescent attention deficit hyperactivity disorder in low and middle-income countries: A narrative review.
    Asian journal of psychiatry, 2022, Volume: 76

    Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervou

2022
Clinical guidance on pharmacotherapy for the treatment of attention-deficit hyperactivity disorder (ADHD) for people with intellectual disability.
    Expert opinion on pharmacotherapy, 2020, Volume: 21, Issue:15

    Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidi

2020
Current and future nonstimulants in the treatment of pediatric ADHD: monoamine reuptake inhibitors, receptor modulators, and multimodal agents.
    CNS spectrums, 2022, Volume: 27, Issue:2

    Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central

2022
A Practical, Evidence-informed Approach to Managing Stimulant-Refractory Attention Deficit Hyperactivity Disorder (ADHD).
    CNS drugs, 2021, Volume: 35, Issue:10

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Atten

2021
Safety, Tolerability and Efficacy of Drugs for Treating Behavioural Insomnia in Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review with Methodological Quality Assessment.
    Paediatric drugs, 2017, Volume: 19, Issue:3

    Topics: Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Eszopiclone; Glutamates; Guanfacine

2017
Impaired reproduction after exposure to ADHD drugs: Systematic review of animal studies.
    The International journal of risk & safety in medicine, 2017, Volume: 29, Issue:1-2

    Topics: Animals; Attention Deficit Disorder with Hyperactivity; Clonidine; Female; Male; Methylphenidate; Re

2017
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.
    The Cochrane database of systematic reviews, 2018, 06-26, Volume: 6

    Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervou

2018
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.
    The lancet. Psychiatry, 2018, Volume: 5, Issue:9

    Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Attention Deficit Disorder with Hyperactivi

2018
A review of the rationale and clinical utilization of α2-adrenoceptor agonists for the treatment of attention-deficit/hyperactivity and related disorders.
    Journal of child and adolescent psychopharmacology, 2013, Volume: 23, Issue:5

    Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Attention Deficit Disorder with Hyperactivity; Clonid

2013
[Autism and attention deficit hyperactivity disorder: pharmacological intervention].
    Revista de neurologia, 2013, Sep-06, Volume: 57 Suppl 1

    Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivi

2013
A review of the use of clonidine as a sleep aid in the child and adolescent population.
    Clinical pediatrics, 2014, Volume: 53, Issue:3

    Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Chi

2014
To sleep or not to sleep: a systematic review of the literature of pharmacological treatments of insomnia in children and adolescents with attention-deficit/hyperactivity disorder.
    Journal of child and adolescent psychopharmacology, 2013, Volume: 23, Issue:10

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Glutamates; Humans; Pyr

2013
Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    The Cochrane database of systematic reviews, 2014, Sep-19, Issue:9

    Topics: Adolescent; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Central

2014
Clonidine Use in Psychiatry: Panacea or Panache.
    Pharmacology, 2016, Volume: 98, Issue:1-2

    Topics: Animals; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Clonidine; Humans; Men

2016
Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review.
    JAMA, 2016, May-10, Volume: 315, Issue:18

    Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Amphetamines; Atomoxetine Hydrochloride; Attention

2016
An Evaluation on the Efficacy and Safety of Treatments for Attention Deficit Hyperactivity Disorder in Children and Adolescents: a Comparison of Multiple Treatments.
    Molecular neurobiology, 2017, Volume: 54, Issue:9

    Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidi

2017
Current and Investigational Medication Delivery Systems for Treating Attention-Deficit/Hyperactivity Disorder.
    The primary care companion for CNS disorders, 2016, Aug-18, Volume: 18, Issue:4

    Topics: Adrenergic Agents; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperact

2016
Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems.
    CNS spectrums, 2016, Volume: 21, Issue:S1

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Anxiety Disorders; Atomoxetine H

2016
Alpha-2 adrenergic agonists in children with inattention, hyperactivity and impulsiveness.
    CNS drugs, 2009, Volume: 23 Suppl 1

    Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Child; Child Development D

2009
The role of alpha2-adrenergic agonists in attention-deficit/hyperactivity disorder.
    Postgraduate medicine, 2010, Volume: 122, Issue:5

    Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervous System Sti

2010
Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders.
    Developmental disabilities research reviews, 2010, Volume: 16, Issue:3

    Topics: Adolescent; Amphetamines; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorde

2010
Another extended-release α2-agonist for ADHD.
    The Medical letter on drugs and therapeutics, 2011, Feb-07, Volume: 53, Issue:1357

    Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Attention Deficit Disorder with Hyperactivity; Child;

2011
Cognitive enhancers for the treatment of ADHD.
    Pharmacology, biochemistry, and behavior, 2011, Volume: 99, Issue:2

    Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child;

2011
Long-term outcomes with medications for attention-deficit hyperactivity disorder: current status of knowledge.
    CNS drugs, 2011, Volume: 25, Issue:7

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Atten

2011
ADHD in children and adolescents.
    BMJ clinical evidence, 2011, Feb-04, Volume: 2011

    Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attentio

2011
Clonidine extended-release: in attention-deficit hyperactivity disorder.
    Paediatric drugs, 2011, Oct-01, Volume: 13, Issue:5

    Topics: Attention Deficit Disorder with Hyperactivity; Clonidine; Delayed-Action Preparations; Humans

2011
New additions to the psychopharmacopia: extended release formulations.
    Issues in mental health nursing, 2011, Volume: 32, Issue:11

    Topics: Adult; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Comparative Effectiveness Re

2011
[α2-Adrenergic agonists, and drugs for ADHD].
    Pharmazie in unserer Zeit, 2011, Volume: 40, Issue:6

    Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Chi

2011
Metabolic, toxicological, and safety considerations for drugs used to treat ADHD.
    Expert opinion on drug metabolism & toxicology, 2012, Volume: 8, Issue:5

    Topics: Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nerv

2012
Revisiting clonidine: an innovative add-on option for attention-deficit/hyperactivity disorder.
    Drugs of today (Barcelona, Spain : 1998), 2012, Volume: 48, Issue:3

    Topics: Adolescent; Adrenergic alpha-Agonists; Amphetamine; Attention Deficit Disorder with Hyperactivity; B

2012
Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.
    Journal of child psychology and psychiatry, and allied disciplines, 2013, Volume: 54, Issue:3

    Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure

2013
Attention deficit hyperactivity disorder in children.
    Clinical evidence, 2002, Issue:7

    Topics: Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants;

2002
[Roles of alpha-2 adrenoceptor in prefrontal cortical cognitive functions].
    Sheng li ke xue jin zhan [Progress in physiology], 1999, Volume: 30, Issue:1

    Topics: Adrenergic alpha-Agonists; Animals; Attention Deficit Disorder with Hyperactivity; Clonidine; Cognit

1999
Attention deficit hyperactivity disorder in children.
    Clinical evidence, 2002, Issue:8

    Topics: Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants;

2002
Tourette's syndrome: are stimulants safe?
    Current neurology and neuroscience reports, 2003, Volume: 3, Issue:4

    Topics: Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clinical

2003
Attention deficit hyperactivity disorder.
    Clinical evidence, 2003, Issue:9

    Topics: Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Combined Modality Therapy; Dextroam

2003
[Chronic tic disorders--chronic mortor or vocal tic disorders and de la Tourette's syndrome].
    Ryoikibetsu shokogun shirizu, 2003, Issue:40

    Topics: Adolescent; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous Sy

2003
Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder.
    The international journal of neuropsychopharmacology, 2004, Volume: 7, Issue:1

    Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Antidepressiv

2004
Pharmacological management of attention-deficit hyperactivity disorder.
    Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:6

    Topics: Adrenergic alpha-Agonists; Amphetamines; Antidepressive Agents; Atomoxetine Hydrochloride; Attention

2004
Clinical inquiries. What is the most effective treatment for ADHD in children?
    The Journal of family practice, 2005, Volume: 54, Issue:2

    Topics: Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants;

2005
The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder.
    Expert opinion on drug safety, 2005, Volume: 4, Issue:2

    Topics: Adrenergic alpha-Agonists; Adult; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Atten

2005
Pharmacological management of treatment-induced insomnia in ADHD.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2005, Volume: 44, Issue:5

    Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimula

2005
ADHD: assessment and intervention.
    Community practitioner : the journal of the Community Practitioners' & Health Visitors' Association, 2005, Volume: 78, Issue:4

    Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior Diso

2005
Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications.
    Pediatrics, 2005, Volume: 115, Issue:6

    Topics: Adolescent; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hypera

2005
Attention deficit hyperactivity disorder in children.
    Clinical evidence, 2005, Issue:13

    Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Combined

2005
Advances in alternative pharmacotherapy of ADHD.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2005, Volume: 88 Suppl 4

    Topics: Adrenergic alpha-Agonists; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperac

2005
Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
    The Journal of clinical psychiatry, 2006, Volume: 67 Suppl 8

    Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Defici

2006
Attention deficit hyperactivity disorder in children.
    Clinical evidence, 2006, Issue:15

    Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Combined

2006
alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data.
    Journal of child and adolescent psychopharmacology, 2007, Volume: 17, Issue:4

    Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Clonidine; Controlled Clin

2007
Recent advances in Gilles de la Tourette syndrome: implications for clinical practice and future research.
    Psychiatric developments, 1983,Autumn, Volume: 1, Issue:3

    Topics: Adolescent; Age Factors; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Compulsive

1983
Disruptive behavior, hyperactivity, and learning disabilities in children with Tourette's syndrome.
    Advances in neurology, 1995, Volume: 65

    Topics: Adolescent; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Child;

1995
Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition.
    Drugs & aging, 1994, Volume: 5, Issue:2

    Topics: Aging; Alcohol Amnestic Disorder; Animals; Attention Deficit Disorder with Hyperactivity; Brain; Clo

1994
Tic disorders.
    Pediatric annals, 1993, Volume: 22, Issue:1

    Topics: Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Child; Child

1993
[Attention deficit disorder with hyperactivity].
    Nederlands tijdschrift voor geneeskunde, 1994, Apr-23, Volume: 138, Issue:17

    Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Child; Child, Pr

1994
Clinical patterns of ADHD: a treatment model based on brain functioning.
    Comprehensive therapy, 1994, Volume: 20, Issue:2

    Topics: Arousal; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior Disorders; Child, Pres

1994
The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder.
    Archives of general psychiatry, 1996, Volume: 53, Issue:5

    Topics: Adrenergic alpha-Agonists; Animals; Attention Deficit Disorder with Hyperactivity; Clonidine; Cognit

1996
Clonidine.
    The Journal of school nursing : the official publication of the National Association of School Nurses, 1995, Volume: 11, Issue:4

    Topics: Adolescent; Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Child; Clonidi

1995
Self-induced overdose of ADHD medication.
    Journal of paediatrics and child health, 1996, Volume: 32, Issue:3

    Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine;

1996
[Attention deficit disorders with hyperactivity in adulthood; implications for diagnosis and treatment].
    Nederlands tijdschrift voor geneeskunde, 1996, Sep-14, Volume: 140, Issue:37

    Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Attention Deficit Disorder with Hyperactivity; Child;

1996
Antidepressants in the treatment of attention-deficit/hyperactivity disorder.
    The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 14

    Topics: Adolescent; Adult; Age Factors; Antidepressive Agents; Antidepressive Agents, Tricyclic; Attention D

1997
The treatment of Tourette's syndrome: multimodal, developmental intervention.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 1

    Topics: Adaptation, Psychological; Adolescent; Adrenergic Agonists; Adult; Age Factors; Antidepressive Agent

1998
Psychoneuroendocrinology of children and adolescents.
    The Psychiatric clinics of North America, 1998, Volume: 21, Issue:2

    Topics: Adolescent; Adolescent Behavior; Attention Deficit Disorder with Hyperactivity; Child; Child Behavio

1998
Aggressive behavior in patients with attention-deficit/hyperactivity disorder, conduct disorder, and pervasive developmental disorders.
    The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 15

    Topics: Adolescent; Aggression; Attention Deficit Disorder with Hyperactivity; Carbamazepine; Child; Child D

1999
A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1999, Volume: 38, Issue:12

    Topics: Adolescent; Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Child; Child B

1999
The Conners' Parent Rating Scales: a critical review of the literature.
    Clinical psychology review, 2001, Volume: 21, Issue:7

    Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervous System Sti

2001
Pharmacological options for the treatment of Tourette's disorder.
    Drugs, 2001, Volume: 61, Issue:15

    Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Botulinum

2001
Pharmacologic treatment of attention deficit hyperactivity disorder.
    The Psychiatric clinics of North America, 1992, Volume: 15, Issue:1

    Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Pres

1992
Pharmacotherapy of Tourette's syndrome and associated disorders.
    The Psychiatric clinics of North America, 1992, Volume: 15, Issue:1

    Topics: Attention Deficit Disorder with Hyperactivity; Clonidine; Female; Haloperidol; Humans; Male; Mental

1992
Clonidine in attention deficit hyperactivity disorder.
    The Annals of pharmacotherapy, 1992, Volume: 26, Issue:1

    Topics: Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Child; Child, Preschool; Clonidine;

1992
[Children with attention deficit disorders with hyperactivity; the role of drugs in treatment].
    Nederlands tijdschrift voor geneeskunde, 1991, Jul-13, Volume: 135, Issue:28

    Topics: Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Child; Child, Presc

1991

Trials

21 trials available for clonidine and ADDH

ArticleYear
Use of sleep medication in children with ADHD.
    Sleep medicine, 2014, Volume: 15, Issue:4

    Topics: Adolescent; Anxiety Disorders; Attention Deficit and Disruptive Behavior Disorders; Attention Defici

2014
Randomised controlled study-efficacy of clonidine versus carbamazepine in children with ADHD.
    Journal of tropical pediatrics, 2009, Volume: 55, Issue:2

    Topics: Adrenergic alpha-Agonists; Analgesics, Non-Narcotic; Attention Deficit Disorder with Hyperactivity;

2009
Effects of clonidine and methylphenidate on family quality of life in attention-deficit/hyperactivity disorder.
    Journal of child and adolescent psychopharmacology, 2009, Volume: 19, Issue:5

    Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervous System Sti

2009
Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2011, Volume: 50, Issue:2

    Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Chi

2011
Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2011, Volume: 50, Issue:2

    Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Chi

2011
Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2011, Volume: 50, Issue:2

    Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Chi

2011
Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2011, Volume: 50, Issue:2

    Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Chi

2011
Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD.
    Pediatrics, 2011, Volume: 127, Issue:6

    Topics: Adolescent; Adolescent Behavior; Adrenergic alpha-2 Receptor Agonists; Amphetamine; Attention Defici

2011
A placebo-controlled study of lofexidine in the treatment of children with tic disorders and attention deficit hyperactivity disorder.
    Journal of psychopharmacology (Oxford, England), 2003, Volume: 17, Issue:1

    Topics: Adolescent; Adrenergic Agonists; Analysis of Variance; Attention Deficit Disorder with Hyperactivity

2003
A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD).
    Current medical research and opinion, 2007, Volume: 23, Issue:2

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with

2007
Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2008, Volume: 47, Issue:2

    Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Bradycardia; Central Nervo

2008
Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2008, Volume: 47, Issue:2

    Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervous System Sti

2008
Use of clonidine in children with autism spectrum disorders.
    Brain & development, 2008, Volume: 30, Issue:7

    Topics: Adolescent; Adrenergic alpha-Agonists; Aggression; Attention Deficit Disorder with Hyperactivity; At

2008
The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.
    Pediatrics, 1995, Volume: 95, Issue:1

    Topics: Adolescent; Analysis of Variance; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; D

1995
Clonidine therapy for comorbid attention deficit hyperactivity disorder and conduct disorder: preliminary findings in a children's inpatient unit.
    Southern medical journal, 1994, Volume: 87, Issue:7

    Topics: Attention Deficit Disorder with Hyperactivity; Blood Pressure; Child; Child Behavior Disorders; Chil

1994
The effect of methylphenidate and clonidine on response inhibition and state regulation in children with ADHD.
    Journal of child psychology and psychiatry, and allied disciplines, 1999, Volume: 40, Issue:2

    Topics: Arousal; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants

1999
A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1999, Volume: 38, Issue:12

    Topics: Adolescent; Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Child; Child B

1999
A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder.
    Clinical pediatrics, 2000, Volume: 39, Issue:1

    Topics: Adolescent; Adrenergic alpha-Agonists; Aggression; Attention Deficit Disorder with Hyperactivity; Ce

2000
Double-blind, placebo-controlled trial of clonidine in hyperactive children with mental retardation.
    Mental retardation, 2001, Volume: 39, Issue:4

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Comorbidity; Dose-Respo

2001
Treatment of ADHD in children with tics: a randomized controlled trial.
    Neurology, 2002, Feb-26, Volume: 58, Issue:4

    Topics: Adolescent; Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervou

2002
Clonidine treatment of hyperactive and impulsive children with autistic disorder.
    Journal of clinical psychopharmacology, 1992, Volume: 12, Issue:5

    Topics: Ambulatory Care; Attention Deficit Disorder with Hyperactivity; Attitude to Health; Autistic Disorde

1992
Clonidine and stuttering.
    The American journal of psychiatry, 1992, Volume: 149, Issue:5

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Female; Humans; Male; S

1992
The therapeutic effect of clonidine in attention deficit disorder with hyperactivity: a comparison with placebo and methylphenidate.
    Psychopharmacology bulletin, 1986, Volume: 22, Issue:1

    Topics: Attention Deficit Disorder with Hyperactivity; Child; Clinical Trials as Topic; Clonidine; Double-Bl

1986
Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial.
    Journal of the American Academy of Child Psychiatry, 1985, Volume: 24, Issue:5

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Clinical Trials as Topic; Clonidin

1985

Other Studies

99 other studies available for clonidine and ADDH

ArticleYear
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
    CNS spectrums, 2023, Volume: 28, Issue:5

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma

2023
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
    CNS spectrums, 2023, Volume: 28, Issue:5

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma

2023
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
    CNS spectrums, 2023, Volume: 28, Issue:5

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma

2023
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
    CNS spectrums, 2023, Volume: 28, Issue:5

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma

2023
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
    CNS spectrums, 2023, Volume: 28, Issue:5

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma

2023
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
    CNS spectrums, 2023, Volume: 28, Issue:5

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma

2023
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
    CNS spectrums, 2023, Volume: 28, Issue:5

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma

2023
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
    CNS spectrums, 2023, Volume: 28, Issue:5

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma

2023
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
    CNS spectrums, 2023, Volume: 28, Issue:5

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma

2023
In utero exposure to ADHD medication and long-term offspring outcomes.
    Molecular psychiatry, 2023, Volume: 28, Issue:4

    Topics: Adult; Amphetamines; Attention Deficit Disorder with Hyperactivity; Child, Preschool; Clonidine; Coh

2023
Efficacy of clonidine in the treatment of children with tic disorder co-morbid with attention deficit hyperactivity disorder.
    European review for medical and pharmacological sciences, 2023, Volume: 27, Issue:9

    Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine;

2023
Pharmacotherapy of Attention Deficit Hyperactivity Disorder Symptom Profile in ASD.
    The Journal of nervous and mental disease, 2017, Volume: 205, Issue:9

    Topics: Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spect

2017
Implications of comorbid ADHD in ASD interventions and outcome: Results from a naturalistic follow up study from south India.
    Asian journal of psychiatry, 2018, Volume: 33

    Topics: Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Autism Spectrum

2018
Methylphenidate-Induced Nocturnal Bruxism Alleviated by Adjunctive Clonidine.
    Journal of child and adolescent psychopharmacology, 2019, Volume: 29, Issue:1

    Topics: Analgesics; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child;

2019
Tourette's syndrome is associated with an increased risk of traumatic brain injury: A nationwide population-based cohort study.
    Parkinsonism & related disorders, 2019, Volume: 63

    Topics: Adolescent; Adult; Antidepressive Agents; Antipsychotic Agents; Attention Deficit Disorder with Hype

2019
Conflicting information from TGA versus FDA may undermine compliance with use of medication.
    The Medical journal of Australia, 2013, Jul-08, Volume: 199, Issue:1

    Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Age Factors; Attention Deficit Disorder with Hyper

2013
Stimulation of postsynapse adrenergic α2A receptor improves attention/cognition performance in an animal model of attention deficit hyperactivity disorder.
    Behavioural brain research, 2014, Aug-15, Volume: 270

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Attention; Attention Defic

2014
Effects of clonidine and methylphenidate on motor activity in Fmr1 knockout mice.
    Neuroscience letters, 2015, Jan-12, Volume: 585

    Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Attention Deficit Disorder with Hyperactivity; Centra

2015
A cost-effectiveness analysis of off-label atypical antipsychotic treatment in children and adolescents with ADHD who have failed stimulant therapy.
    Attention deficit and hyperactivity disorders, 2016, Volume: 8, Issue:3

    Topics: Adolescent; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperac

2016
Treating ADHD in Prison: Focus on Alpha-2 Agonists (Clonidine and Guanfacine).
    The journal of the American Academy of Psychiatry and the Law, 2016, Volume: 44, Issue:2

    Topics: Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Clonidine; Guan

2016
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.
    BMJ open, 2017, 01-10, Volume: 7, Issue:1

    Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Attention Deficit Disorder with Hyperactivi

2017
Insomnia, night terror, and depression related to clonidine in attention-deficit/hyperactivity disorder.
    Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:6

    Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervous System Sti

2008
Attention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy.
    Drugs, 2010, Volume: 70, Issue:1

    Topics: Administration, Oral; Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperac

2010
In the pipeline: non-stimulant ADHD meds.
    Behavioral healthcare, 2010, Volume: 30, Issue:1

    Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Clonidine; Guanfacine; Hum

2010
Cortical and hippocampal EEG effects of neurotransmitter agonists in spontaneously hypertensive vs. kainate-treated rats.
    Brain research, 2011, Apr-06, Volume: 1383

    Topics: Animals; Attention Deficit Disorder with Hyperactivity; Baclofen; Clonidine; Disease Models, Animal;

2011
Clonidine: diverse use in pharmacologic management.
    Perspectives in psychiatric care, 2011, Volume: 47, Issue:2

    Topics: Adolescent; Adult; Asperger Syndrome; Attention Deficit Disorder with Hyperactivity; Autistic Disord

2011
Treatment experiences of children and adolescents with attention-deficit/hyperactivity disorder.
    Journal of paediatrics and child health, 2011, Volume: 47, Issue:8

    Topics: Adolescent; Adolescent Behavior; Attention Deficit Disorder with Hyperactivity; Australia; Central N

2011
Treatment practices in Tourette syndrome: the European perspective.
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2012, Volume: 16, Issue:4

    Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride

2012
Successful treatment of severe disruptive disorder featuring symptoms of the Klüver-Bucy Syndrome following a massive right temporal-parietal hemorrhage.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2013, Volume: 34, Issue:1

    Topics: Adrenergic alpha-Agonists; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Di

2013
Clonidine extended-release in attention-deficit hyperactivity disorder: profile report.
    CNS drugs, 2012, Mar-01, Volume: 26, Issue:3

    Topics: Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Clonidine; Dela

2012
Sapophagia (compulsive soap eating) and attention-deficit/hyperactivity disorder in a child responsive to clonidine.
    Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:2

    Topics: Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Child; Clonidin

2012
Clonidine utilization trends for Medicaid children.
    Clinical pediatrics, 2012, Volume: 51, Issue:10

    Topics: Adolescent; Antihypertensive Agents; Attention Deficit Disorder with Hyperactivity; Child; Clonidine

2012
Treatment patterns, adherence, and persistence in ADHD: a Canadian perspective.
    Postgraduate medicine, 2012, Volume: 124, Issue:3

    Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Analysis of Variance

2012
Psychopharmacology for the clinician: management of comorbid Tourette syndrome and attention-deficit/hyperactivity disorder: are psychostimulants an option?
    Journal of psychiatry & neuroscience : JPN, 2012, Volume: 37, Issue:6

    Topics: Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervous

2012
Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008.
    Psychiatric services (Washington, D.C.), 2013, Apr-01, Volume: 64, Issue:4

    Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Amphetamines; Atomox

2013
Pediatric clonidine poisoning as a result of pharmacy compounding error.
    Pediatric emergency care, 2002, Volume: 18, Issue:4

    Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Drug Com

2002
[Medical treatment of fragile X syndrome].
    Revista de neurologia, 2001, Volume: 33 Suppl 1

    Topics: Adrenergic alpha-Agonists; Anticonvulsants; Antipsychotic Agents; Attention Deficit and Disruptive B

2001
Ritalin is okay for kids with both ADHD and Tourette's syndrome, study says.
    Report on medical guidelines & outcomes research, 2002, Mar-22, Volume: 13, Issue:6

    Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clinical Tr

2002
Clonidine for self-injurious behavior.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2004, Volume: 43, Issue:11

    Topics: Administration, Oral; Adolescent; Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperac

2004
Methylphenidate an effective treatment for ADHD?
    Journal of autism and developmental disorders, 2004, Volume: 34, Issue:5

    Topics: Adrenergic alpha-Agonists; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Auti

2004
In vitro and in vivo characterization of a newly developed clonidine transdermal patch for treatment of attention deficit hyperactivity disorder in children.
    Biological & pharmaceutical bulletin, 2005, Volume: 28, Issue:2

    Topics: Administration, Cutaneous; Animals; Attention Deficit Disorder with Hyperactivity; Child; Clonidine;

2005
The use of clonidine for severe and intractable sleep problems in children with neurodevelopmental disorders--a case series.
    European child & adolescent psychiatry, 2005, Volume: 14, Issue:1

    Topics: Adolescent; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Brain; Child; Cloni

2005
How should we evaluate and treat ADHD in children and adolescents?
    The Journal of family practice, 2005, Volume: 54, Issue:12

    Topics: Adolescent; Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Behavior Thera

2005
Case report: clonidine withdrawal after atypically high-dose maintenance treatment.
    Journal of paediatrics and child health, 2005, Volume: 41, Issue:11

    Topics: Adolescent; Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Clonidine; Hum

2005
Clonidine-induced gynecomastia and hyperprolactinemia in a 6-year-old child.
    The Journal of clinical psychiatry, 2005, Volume: 66, Issue:12

    Topics: Age Factors; Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Comor

2005
New developments in the treatment of ADHD.
    The Journal of clinical psychiatry, 2006, Volume: 67, Issue:1

    Topics: Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperac

2006
Nonstimulant medications for the treatment of ADHD.
    Journal of child and adolescent psychiatric nursing : official publication of the Association of Child and Adolescent Psychiatric Nurses, Inc, 2006, Volume: 19, Issue:1

    Topics: Adrenergic alpha-Agonists; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention De

2006
ADHD and insomnia.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2006, Volume: 45, Issue:4

    Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimula

2006
Less is more: inpatient management of a child with complex pharmacotherapy.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2006, Volume: 45, Issue:5

    Topics: Aggression; Amphetamines; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Depressio

2006
Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome.
    Journal of child and adolescent psychopharmacology, 2006, Volume: 16, Issue:3

    Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivi

2006
Decreased use of clonidine following treatment with atomoxetine in children with ADHD.
    Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:4

    Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Atte

2006
Trichotillomania and co-morbid psychiatric disorders in a 10-year-old boy.
    Journal of child and adolescent psychopharmacology, 2007, Volume: 17, Issue:1

    Topics: Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Comorbidity; Drug Therapy, Combinat

2007
Intranasal clonidine as a premedicant: three cases with unique indications.
    Paediatric anaesthesia, 2008, Volume: 18, Issue:1

    Topics: Administration, Intranasal; Adrenergic alpha-Agonists; Asthma; Attention Deficit Disorder with Hyper

2008
New-onset seizures: a possible association with clonidine?
    Pediatric neurology, 2008, Volume: 38, Issue:2

    Topics: Adrenergic alpha-Agonists; Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Cerebral

2008
Development of tics in a thirteen-year-old male following atomoxetine use.
    CNS spectrums, 2008, Volume: 13, Issue:4

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Anticonvulsants; Atomoxetine Hydrochloride; Attention Defi

2008
Strategies for study of the neurochemistry of attention deficit disorder in children.
    Schizophrenia bulletin, 1982, Volume: 8, Issue:2

    Topics: Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Dopamine beta-Hydroxylase; Growth H

1982
Possible change in noradrenergic receptor sensitivity following methylphenidate treatment: growth hormone and MHPG response to clonidine challenge in children with attention deficit disorder and hyperactivity.
    Life sciences, 1984, Aug-20, Volume: 35, Issue:8

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior; Clonidine; Drug In

1984
Gilles de la Tourette's syndrome. An overview of clinical experience.
    Journal of the American Academy of Child Psychiatry, 1984, Volume: 23, Issue:2

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Clonidine; Compu

1984
Growth hormone response to clonidine in children ages 4-17: Tourette's syndrome vs. children with short stature.
    Journal of the American Academy of Child Psychiatry, 1984, Volume: 23, Issue:2

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Body Height; Child; Child, Preschool; Clo

1984
Animal models of neuropsychiatric disorders and their relevance for Tourette syndrome.
    Advances in neurology, 1982, Volume: 35

    Topics: Animals; Attention Deficit Disorder with Hyperactivity; Clonidine; Disease Models, Animal; Dopamine;

1982
Pediatricians' knowledge and attitudes concerning diagnosis and treatment of attention deficit and hyperactivity disorders. A national survey approach.
    Archives of pediatrics & adolescent medicine, 1995, Volume: 149, Issue:11

    Topics: Adult; Aged; Amphetamines; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperac

1995
Combined pharmacotherapy: an emerging trend in pediatric psychopharmacology.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1995, Volume: 34, Issue:1

    Topics: Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Child Psychiatry;

1995
Case study: behavioral symptoms of pediatric HIV-1 encephalopathy successfully treated with clonidine.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1995, Volume: 34, Issue:3

    Topics: AIDS Dementia Complex; Attention Deficit Disorder with Hyperactivity; Child, Preschool; Clonidine; H

1995
Adderall and other drugs for attention-deficit/hyperactivity disorder.
    The Medical letter on drugs and therapeutics, 1994, Nov-25, Volume: 36, Issue:936

    Topics: Amphetamines; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous

1994
Alpha-2-adrenoceptor sensitivity in heroin addicts with and without previous attention deficit disorder/hyperactivity and conduct disorder.
    Neuropsychobiology, 1994, Volume: 30, Issue:1

    Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; beta-Endorphin; Clonidine; Growth

1994
Extended-release clonidine for sleep disorders.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1994, Volume: 33, Issue:8

    Topics: Adolescent; Arousal; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Delayed-Action

1994
Children who have attentional disorders: interventions.
    Pediatrics in review, 1994, Volume: 15, Issue:1

    Topics: Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; C

1994
Attention deficit hyperactivity disorder in adults: diagnosis, treatment, and prognosis.
    Southern medical journal, 1994, Volume: 87, Issue:3

    Topics: Adult; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Clonidine; D

1994
Safety of clonidine and nortriptyline.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1994, Volume: 33, Issue:1

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Drug Therapy, Combinati

1994
Clonidine for stimulant-related sleep problems.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1994, Volume: 33, Issue:2

    Topics: Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Dextroamphetamine; Drug Therapy, Co

1994
Nortriptyline treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1993, Volume: 32, Issue:1

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Comorbidity; Family Hea

1993
Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1993, Volume: 32, Issue:1

    Topics: Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Clonidine; Desipramine; Female; Hum

1993
Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1993, Volume: 32, Issue:2

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Clonidine; Comor

1993
Medication for children with attentional disorders. American Academy of Pediatrics Committee on Children With Disabilities and Committee on Drugs.
    Pediatrics, 1996, Volume: 98, Issue:2 Pt 1

    Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity;

1996
Attention-deficit disorder with hyperactivity.
    The Medical journal of Australia, 1996, Aug-05, Volume: 165, Issue:3

    Topics: Attention Deficit Disorder with Hyperactivity; Child, Preschool; Clonidine; Drug Overdose; Female; H

1996
Clonidine: a practical guide for usage in children.
    South Dakota journal of medicine, 1996, Volume: 49, Issue:7

    Topics: Administration, Cutaneous; Administration, Oral; Adrenergic alpha-Agonists; Attention Deficit Disord

1996
Predictors of clonidine response in Tourette syndrome: implications and inferences.
    Journal of child neurology, 1996, Volume: 11, Issue:2

    Topics: Adolescent; Adrenergic alpha-Agonists; Age Factors; Attention Deficit Disorder with Hyperactivity; C

1996
Attention deficit disorder.
    The British journal of psychiatry : the journal of mental science, 1996, Volume: 169, Issue:4

    Topics: Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Comorbidity; Humans; Psychotropic D

1996
Assessment and diagnosis of attention deficit/hyperactivity disorder in pediatric general practice.
    Missouri medicine, 1996, Volume: 93, Issue:9

    Topics: Antidepressive Agents, Tricyclic; Antihypertensive Agents; Attention Deficit Disorder with Hyperacti

1996
Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1996, Volume: 35, Issue:5

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Clonidine; Dose-

1996
Clonidine for treatment of attention-deficit/hyperactivity disorder.
    The Medical letter on drugs and therapeutics, 1996, Dec-06, Volume: 38, Issue:989

    Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervous System; Ce

1996
Case study: adverse response to clonidine.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1997, Volume: 36, Issue:4

    Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Fatal Ou

1997
Fragile X: treatment of hyperactivity.
    Pediatrics, 1997, Volume: 99, Issue:5

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child;

1997
Clonidine poisoning--an emerging problem: epidemiology, clinical features, management and preventative strategies.
    Journal of paediatrics and child health, 1998, Volume: 34, Issue:3

    Topics: Attention Deficit Disorder with Hyperactivity; Charcoal; Child; Child Behavior Disorders; Child, Pre

1998
Clinical guidelines for hyperkinetic disorder. European Society for Child and Adolescent Psychiatry.
    European child & adolescent psychiatry, 1998, Volume: 7, Issue:4

    Topics: Adolescent; Adrenergic alpha-Agonists; Antidepressive Agents; Attention Deficit Disorder with Hypera

1998
Case study: accidental clonidine patch overdose in attention-deficit/hyperactivity disorder patients.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1999, Volume: 38, Issue:1

    Topics: Administration, Cutaneous; Adolescent; Adrenergic alpha-Agonists; Attention Deficit Disorder with Hy

1999
Clonidine: adverse responses.
    Journal of paediatrics and child health, 1998, Volume: 34, Issue:6

    Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Child; Clo

1998
Clonidine overdose in childhood: implications of increased prescribing.
    Journal of paediatrics and child health, 1998, Volume: 34, Issue:6

    Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Bradycardia; Child; Child,

1998
Combining methylphenidate and clonidine: a clinically sound medication option.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1999, Volume: 38, Issue:5

    Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Aggression; Antihypertensive Agents; Attention

1999
Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment.
    The Journal of nervous and mental disease, 1999, Volume: 187, Issue:8

    Topics: Adult; Ambulatory Care; Attention; Attention Deficit Disorder with Hyperactivity; Clonidine; Cogniti

1999
Case series: clonidine has no systematic effects on PR or QTc intervals in children.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1999, Volume: 38, Issue:9

    Topics: Adolescent; Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervou

1999
Clonidine and methylphenidate.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1999, Volume: 38, Issue:12

    Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine;

1999
Drugged-out toddlers. A new study documents an alarming increase in behavior-altering medication for preschoolers.
    Newsweek, 2000, Mar-06, Volume: 135, Issue:10

    Topics: Age Factors; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous S

2000
[Attention deficit disorder with hyperactivity in children: diagnosis and therapeutic management].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2000, Volume: 7, Issue:10

    Topics: Adolescent; Adrenergic alpha-Agonists; Antidepressive Agents; Attention Deficit Disorder with Hypera

2000
A 1000-fold overdose of clonidine caused by a compounding error in a 5-year-old child with attention-deficit/hyperactivity disorder.
    Pediatrics, 2001, Volume: 108, Issue:2

    Topics: Adrenergic alpha-Agonists; Antihypertensive Agents; Attention Deficit Disorder with Hyperactivity; C

2001
[Functioning, comorbidity and treatment of 141 adults with attention deficit hyperactivity disorder (ADHD) at a psychiatric outpatient department].
    Nederlands tijdschrift voor geneeskunde, 2001, Aug-04, Volume: 145, Issue:31

    Topics: Adrenergic alpha-Agonists; Adult; Age Factors; Attention Deficit Disorder with Hyperactivity; Centra

2001
[Therapy of tic disorders apparently of organic origin in a multi-morbid 5-year-old patient with lofexidine (Britlofex) and clonidine (Catapressan)].
    Wiener medizinische Wochenschrift (1946), 2001, Volume: 151, Issue:13-14

    Topics: Affective Symptoms; Aggression; Attention Deficit Disorder with Hyperactivity; Brain Damage, Chronic

2001
Trends and toxic effects from pediatric clonidine exposures.
    Archives of pediatrics & adolescent medicine, 2002, Volume: 156, Issue:4

    Topics: Adolescent; Adrenergic alpha-Agonists; Age Distribution; Attention Deficit Disorder with Hyperactivi

2002
Use of medication by young people with attention-deficit/hyperactivity disorder.
    The Medical journal of Australia, 2002, Jul-01, Volume: 177, Issue:1

    Topics: Adolescent; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Australia; Central

2002
Clonidine in hyperkinetic children.
    Activitas nervosa superior, 1990, Volume: 32, Issue:1

    Topics: Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Dibenzothiepi

1990
The clonidine patch and behavior problems.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1990, Volume: 29, Issue:4

    Topics: Administration, Cutaneous; Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child B

1990
[The treatment of children with Gilles de la Tourette's syndrome].
    Tijdschrift voor kindergeneeskunde, 1987, Volume: 55, Issue:1

    Topics: Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Haloperidol;

1987
Parotid gland salivary secretion in Tourette's syndrome and attention deficit disorder: a model system for the study of neurochemical regulation.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1987, Volume: 26, Issue:1

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Female; Humans; Male; P

1987
Tourette's syndrome in Monroe County school children.
    Neurology, 1988, Volume: 38, Issue:3

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior; Child; Child, Preschool; Clonid

1988
Neuroendocrine aspects of attention deficit hyperactivity disorder.
    Neurologic clinics, 1988, Volume: 6, Issue:1

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Growth Hormone; Humans;

1988
Treatment effects of oral and transdermal clonidine in relation to methylphenidate: an open pilot study in ADD-H.
    Psychopharmacology bulletin, 1987, Volume: 23, Issue:1

    Topics: Administration, Cutaneous; Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Clonidi

1987
Is clonidine a behavioural teratogen in the human?
    Early human development, 1986, Volume: 14, Issue:1

    Topics: Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Clonidine; Dose-Response Rel

1986